Expression of maspin and KAI1 and their clinicopathological significance in carcinogenesis and progression of gastric cancer

Chinese Medical Sciences Journal

Volumn 19, Issue 3, 2004, Pages 193-198

  Zheng, Hua Chuan ^a   Wang, Meng Chun ^a   Li, Jin Yi ^b   Yang, Xue Fei ^a   Sun, Jin Min ^a   Xin, Yan ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b GENERAL HOSPITAL OF CHINESE PEOPLE'S ARMED POLICE FORCES   (China)

Author keywords

Carcinogenesis; Kail; Maspin; Progression; Stomach neoplasms

Indexed keywords

CD82 ANTIGEN; CELL PROTEIN; MASPIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER GROWTH; CANCER SIZE; CANCER STAGING; CONTROLLED STUDY; DYSPLASIA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PROTEIN EXPRESSION; STOMACH CANCER; STOMACH CARCINOGENESIS;

ADENOCARCINOMA; ANTIGENS, CD; CARCINOGENICITY TESTS; GENES, TUMOR SUPPRESSOR; HUMANS; HYPERPLASIA; KANGAI-1 PROTEIN; LYMPHATIC METASTASIS; MEMBRANE GLYCOPROTEINS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROTEINS; PROTO-ONCOGENE PROTEINS; SERPINS; STOMACH; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 5444225225     PISSN: 10019294     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Debies MT, Welch DR. Genetic basis of human breast cancer metastasis. J Mammary Gland Biol Neoplasia 2001;6:441-51.
2. Maass N, Hojo T, Zhang M, et al. Maspin-a novel protease inhibitor with tumor-suppressing activity in breast cancer. Acta Oncol 2000;39:931-4.
3. Uzawa K, Ono K, Suzuki H, et al. High prevalence of decreased expression of kai1 metastasis suppressor in human oral carcinogenesis. Clin Cancer Res 2002;8:828-35.
4. Yang L, Kuang LG, Zheng HC, et al. PTEN encoding product: a marker for tumorigenesis and progression of gastric carcinoma. World J Gastroenterol 2003;9:35-9.
5. Maass N, Biallek M, Rosel F, et al. Hypermethylation and histone deacetylation lead to silencing of the maspin gene in human breast cancer. Biochem Biophys Res Commun 2002;297:125-8.
6. Spring P, Nakashima T, Frederick M, et al. Identification and cDNA cloning of headpin, a novel differentially expressed serpin that maps to chromosome 18q. Biochem Biophys Res Commun 1999;264:299-304.
7. Biliran H Jr, Sheng S. Pleiotrophic inhibition of pericellular urokinase-type plasminogen activatorsystem by endogenous tumor suppressive maspin. Cancer Res 2001;61:8676-82.
8. Blacque OE, Worrall DM. Evidence for a direct interaction between the tumour suppressor serpin maspin, and types I and III collagen. J Biol Chem 2002;277:10783-8.
9. Seftor RE, Seftor EA, Sheng S, et al. Maspin suppresses the invasive phenotype of human breast carcinoma. Cancer Res 1998;58:5681-5.
10. Zhang M, Volpert O, Shi YH, et al. Maspin is an angiogenesis inhibitor. Nat Med 2000;6:196-9.
11. Jiang N, Meng Y, Zhang S, et al. Maspin sensitizes breast carcinoma cells to induced apoptosis. Oncogene 2002;21:4089-98.
12. Marreiros A, Czolij R, Yardley G, et al. Identification of regulatory regions with the kai1 promoter: a role for binding of AP1, AP2 and p53. Gene 2003;302:155-64.
13. Jee B, Jin K, Hahn JH, et al. Metastasis-suppressor kai1/CD82 induces homotypic aggregation of human prostate cancer cells through Src-dependent pathway. Exp Mol Med 2003;35:30-7.
14. Hashida H, Takabayashi A, Tokuhara T, et al. Integrin alpha3 expression as a prognostic factor in colon cancer: association with MRP-1/CD9 and kai1/CD82. Int J Cancer 2002;97:518-25.